acute coronary syndrome and myocardial infarction with non-obstructive arteries
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who understood the contents of the written informed consent provided by the research director or co-investigator and signed the consent form in their own handwriting or by their representative. Patients diagnosed with acute myocardial infarction and MINOCA who underwent emergency coronary angiography and/or percutaneous coronary intervention due to clinical necessity.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diseases of patients who underwent emergency cardiac catheterization and/or percutaneous coronary intervention for acute coronary syndrome or MINOCA (acute coronary syndrome [STEMI, NSTEMI, UAP], MINOCA [plaque rupture/erosion, coronary spasm, coronary artery Dissection, acute aortic dissection, microangiopathy, coronary thrombosis [due to thrombotic predisposition], coronary embolism, sympathomimetic drugs [cocaine, methamphetamine], myocarditis, Takotsubo cardiomyopathy, other cardiomyopathy, cardiac trauma, excessive exercise, Tachyarrhythmia, drug-induced myocardial injury [chemotherapy], disruption of oxygen supply and demand balance [type-2 myocardial infarction], cerebral infarction, pulmonary thromboembolism, sepsis, acute respiratory distress syndrome, end-stage renal failure, cause unknown]) ratio of | — |
Countries
Japan
Contacts
Wakayama Medical University Department of Cardiovascular Medicine